Hi jessica211,
It is not wishful thinking. If you refer to page 10 of "Annual General meeting Presentation" dated 30/11/2017, it said the following:
PMA filed 28 Sep 2017
- Granted priority review
- 90% of PMAs without advisory committee reach decision 180 FDA days after filing
- 90% of PMAs with advisory reach decision 320 FDA days after filing.
- Consistent engagement with FDA through Expedited Access Pathway (EAP) has reduced regulatory risk.
We are now into about 260 days since filing and based on the above, I suspect we will hear the decision between July and September. I am actually surprised why it takes so long and we haven't got a decision now, cause of our EAP status and granted priority review??? It is a bit disappointing though.
Hi jessica211, It is not wishful thinking. If you refer to page...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.63 |
Change
0.160(6.48%) |
Mkt cap ! $179.0M | |||
| Open | High | Low | Value | Volume |
| $2.54 | $2.64 | $2.54 | $874.2K | 336.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3056 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.63 | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |